| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/11/2014 | US20140364401 Antispasmodic 1,2-diols and 1,2,3-triols |
| 12/11/2014 | US20140364390 Xyloglucan-based compositions for the treatment of gastrointestinal disorders |
| 12/11/2014 | US20140363529 Compounds influencing fatty acid uptake and metabolism and methods of isolating from cocoa products |
| 12/11/2014 | US20140363523 Deuterated alpha-lipoic acid |
| 12/11/2014 | US20140363522 Compositions and Methods for Treating and/or Preventing Cancer by Inhibiting Fatty Acid Binding Proteins |
| 12/11/2014 | US20140363518 Antiviral therapy with a whole, leech saliva extract |
| 12/11/2014 | US20140363516 Multiple unit pellet tablet formulation comprising an opioid |
| 12/11/2014 | US20140363514 Core-shell particle formulation for delivering multiple therapeutic agents |
| 12/11/2014 | US20140363502 Resveratrol-Containing Compositions and Methods of Use for Treatment of Macular Degeneration |
| 12/11/2014 | US20140363500 Use of an antibody and a particulate immunomodulator |
| 12/11/2014 | US20140363497 Nanocell Drug Delivery System |
| 12/11/2014 | US20140363495 Native and agonist ctl epitopes of the muc1 tumor antigen |
| 12/11/2014 | US20140363486 Methods for reducing or altering scar formation |
| 12/11/2014 | US20140363479 Compositions and methods for treating extracellular parasitic infections |
| 12/11/2014 | US20140363446 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 12/11/2014 | US20140363443 Tricyclic carbamate jak inhibitors |
| 12/11/2014 | US20140363432 Vascular endothelial cell growth factor antagonists and uses thereof |
| 12/11/2014 | US20140363429 Binding molecules specific for her3 and uses thereof |
| 12/11/2014 | US20140363423 Peptide compounds for inhibition of platelet aggregation |
| 12/11/2014 | US20140363422 Method of providing monoclonal auto-antibodies with desired specificity |
| 12/11/2014 | US20140363409 Lactobacillus Reuteri DSM 17938 for the Development of the Enteric Nervous System |
| 12/11/2014 | US20140363402 Composition and method for muscle repair and regeneration |
| 12/11/2014 | US20140363396 Once daily treatment of hepatitis c with ribavirin and taribavirin |
| 12/11/2014 | US20140363395 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 12/11/2014 | US20140363391 System and method for administering poloxamers and anesthetics while performing cpr and minimizing reperfusion injury |
| 12/11/2014 | US20140363377 Procaspase 8-mediated disease targeting |
| 12/10/2014 | CN1767831B 包含甲基纳曲酮的药物配方 Containing methylnaltrexone pharmaceutical formulations |
| 12/10/2014 | CN104204082A 高分子化氮氧化合物与无机颗粒的有机-无机杂合复合物 Organic macromolecular nitroxide compound and inorganic particles - inorganic hybrid composite |
| 12/10/2014 | CN104203279A 脑癌的治疗 Brain cancer treatment |
| 12/10/2014 | CN104203246A 治疗妇科疾病的方法 Method of treatment of gynecological diseases |
| 12/10/2014 | CN104203227A 用于抑制或治疗多重耐药细菌的富里酸与抗生素组合物 For inhibiting or treating multi-drug resistant bacteria and antibiotic fulvic acid composition |
| 12/10/2014 | CN104195146A 肝硬化微生物标志物及应用 Cirrhosis and application of microbial markers |
| 12/10/2014 | CN104195145A 肝硬化的生物标志物及其应用 Cirrhosis biomarkers Its Applications |
| 12/10/2014 | CN104193982A 一种聚乙二醇单甲醚修饰的介孔二氧化硅纳米颗粒及其制备方法和用途 One polyethylene glycol monomethyl ether-modified mesoporous silica nanoparticles and their preparation and use |
| 12/10/2014 | CN104193802A 多种化合物 Various compounds |
| 12/10/2014 | CN104193791A 用于治疗黄病毒感染的修饰的2'和3'-核苷前药 2 'and 3'-modified nucleoside prodrugs for the treatment of flavivirus infection |
| 12/10/2014 | CN104193779A 一种pH敏感磷脂药用材料及其制备方法与应用 A sensitive phospholipid medicinal material and preparation method and application of pH |
| 12/10/2014 | CN104193725A 有机化合物 Organic compounds |
| 12/10/2014 | CN104189925A 一种新型造影材料、其制备方法及应用 A new type of contrast material, and its preparation method and application |
| 12/10/2014 | CN104189916A 一种多聚体白蛋白纳米球及其制备方法和应用 A multi-mer albumin nanospheres and its preparation method and application |
| 12/10/2014 | CN104189909A 肾上腺素受体拮抗剂在制备缓解脑损伤引起钠电流增加的药物中应用 Adrenergic receptor antagonists used in the preparation of sodium currents relieve brain damage caused by the increase in drug |
| 12/10/2014 | CN104189908A 包含藻酸盐低聚物的产品、包含无生命表面的产品和清创组合物 Comprising alginate oligomer products, comprising products and inanimate surface debridement compositions |
| 12/10/2014 | CN104189907A 伴有脉络膜血管生成的疾病的治疗药 Choroidal angiogenesis therapeutic agent for diseases |
| 12/10/2014 | CN104189906A 用于治疗糖尿病并发症的药用组合物 Pharmaceutical composition for the treatment of diabetic complications |
| 12/10/2014 | CN104189905A 包含水难溶性药剂和抗微生物剂的组合物 The composition comprises a water-soluble agent and an antimicrobial agent |
| 12/10/2014 | CN104188943A 使用α-羟基羰基化合物作为还原剂 Using α- hydroxy carbonyl compound as the reducing agent |
| 12/10/2014 | CN104188938A 控释药物蚊虫叮咬贴 Controlled release drug mosquito bites stickers |
| 12/10/2014 | CN104188937A 一种镶嵌蒙脱石的固体脂质纳米粒制剂及其制备方法 A mosaic of solid lipid nanoparticles of montmorillonite and its preparation method |
| 12/10/2014 | CN104188926A 化学物质的胶束纳米颗粒 Micellar nanoparticles chemicals |
| 12/10/2014 | CN103319579B 黄曲霉中与唑类药物敏感性相关的蛋白afla-216及其编码基因与应用 Aflatoxin with azole susceptibility associated afla-216 protein-coding genes and its application |
| 12/10/2014 | CN103251561B 一种双敏感可崩解式纳米囊泡药物载体制剂及其制备方法 A two-sensitive nano-vesicles may disintegrate type drug carrier and its preparation method |
| 12/10/2014 | CN103006565B 一种纳米颗粒药物组合物及其制备方法 One nanoparticle drug composition and preparation method |
| 12/10/2014 | CN102988985B miR-146a作为调节血管生长靶标的用途 miR-146a as the regulation of vascular growth target use |
| 12/10/2014 | CN102921007B 防治胰岛素抵抗和糖尿病的方法和试剂 Insulin resistance and diabetes prevention methods and reagents |
| 12/10/2014 | CN102732608B 一种诊断肝癌的标记物及其应用 A method of diagnosing liver cancer marker Its Applications |
| 12/10/2014 | CN102698276B 抗hiv治疗期间使用的组合物和方法 The compositions and methods used during the treatment of anti-hiv |
| 12/10/2014 | CN102614514B Glp-1受体激动剂用于治疗疼痛 Glp-1 receptor agonists for the treatment of pain |
| 12/10/2014 | CN102580091B 增强阿片镇痛剂的镇痛作用的方法及试剂 Methods to enhance the analgesic effect of opioid analgesics and reagents |
| 12/10/2014 | CN102366429B 中草药羌活提取物在制备减肥降脂药物或制备具有脂肪酶活性抑制作用的药物中的应用 Notopterygium herbal extract in preparing lipid-lowering diet drugs or preparation having lipase activity inhibitory drug application |
| 12/10/2014 | CN102357109B 中草药白薇提取物在制备减肥降脂药物或制备具有脂肪酶活性抑制作用的药物中的应用 Bai Wei herbal extract in preparing lipid-lowering diet drugs or preparation having lipase activity inhibitory drug application |
| 12/10/2014 | CN102321626B 用于抑制蛋白激酶3表达的方法 Method for inhibiting the expression of protein kinase 3 |
| 12/10/2014 | CN101678078B Sparc及其使用方法 Sparc and methods of use |
| 12/09/2014 | US8907131 Compounds for treating proliferative disorders |
| 12/09/2014 | US8907109 Methods and systems for treating cell proliferation disorders with psoralen derivatives |
| 12/09/2014 | US8907101 Sulfonamide derivatives |
| 12/09/2014 | US8907086 Fused bicyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors |
| 12/09/2014 | US8907072 Nucleic acids encoding antibody 137-26 which binds C5 and C5a |
| 12/09/2014 | US8907057 Peptides that target dorsal root ganglion neurons |
| 12/09/2014 | US8906962 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| 12/09/2014 | US8906958 Compounds and mixtures for influencing inflammatory states |
| 12/09/2014 | US8906945 Inhibitors of bacterial type III secretion system |
| 12/09/2014 | US8906936 Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereof |
| 12/09/2014 | US8906932 Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4Hquinazolin-3-yl)-piperidine-2,6-dione |
| 12/09/2014 | US8906929 Inhibitors of human immunodeficiency virus replication |
| 12/09/2014 | US8906922 Substituted triazoles useful as AXl inhibitors |
| 12/09/2014 | US8906907 Hypotensive lipid and timolol compositions and methods of using same |
| 12/09/2014 | US8906903 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 12/09/2014 | US8906901 Administration of dipeptidyl peptidase inhibitors |
| 12/09/2014 | US8906896 Platinum acridine anti-cancer compounds and methods thereof |
| 12/09/2014 | US8906889 C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
| 12/09/2014 | US8906887 C7-fluoro substituted tetracycline compounds |
| 12/09/2014 | US8906885 Treating cancer with HSP90 inhibitory compounds |
| 12/09/2014 | US8906880 Nucleoside phosphoramidate prodrugs |
| 12/09/2014 | US8906858 Method for the prophylactic or therapeutic treatment of glucocorticoid-induced osteoporosis |
| 12/09/2014 | US8906855 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 12/09/2014 | US8906854 Methods for treating metabolic disorders using FGF |
| 12/09/2014 | US8906853 [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection |
| 12/09/2014 | US8906846 Method of treating inflammatory bowel disease by administering a clip-inducing agent |
| 12/09/2014 | US8906845 Peptide compounds to regulate the complement system |
| 12/09/2014 | US8906427 Treatment for meibomian gland dysfunction or obstruction |
| 12/09/2014 | US8906406 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
| 12/09/2014 | US8906396 High-loading, controlled-release magnesium oral dosage forms and methods for making and using same |
| 12/09/2014 | US8906393 Biofilm inhibiting composition |
| 12/09/2014 | US8906390 Synthetic lipid rafts and methods of use |
| 12/09/2014 | US8906380 Fungal immunostimulatory compositions |
| 12/09/2014 | US8906378 Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases |
| 12/09/2014 | US8906374 Combination therapy with CD4 lymphocyte depletion and mTOR inhibitors |
| 12/09/2014 | US8906357 Treatment of multiple sclerosis with masitinib |
| 12/09/2014 | US8904664 Dehydration device and methods for drying biological materials |
| 12/04/2014 | US20140357724 Beta 2 adrenoceptor antagonists for treating orthostatic hypotension |